Australia is a compelling destination to develop, commercialise, scale and source the next generation of digital health technologies.

We have a strong track record in health. As the inventors of the Cochlear implant, spray-on skin, the cervical cancer vaccine and a cure for peptic ulcers, Australian health and medical research is changing lives for the better.

Australia has embraced digital health to provide new ways of delivering services and to radically transform current processes, improve outcomes and increase efficiencies, creating opportunities for collaboration and investment.

The Australian Government is continuing to invest in digital health infrastructure, and notable projects include:

  • A National Digital Health Strategy, with pioneering initiatives co-produced between consumers, governments, researchers, providers and industry. This includes a framework for secondary data use
  • My Health Record, a personally controlled electronic health record covering over 90% of Australian residents
  • The $20 billion Medical Research Future fund, the largest endowment fund of its kind in the world.

62% of Australians are using technology to better manage their health. 91% believe technology can help them better manage their health. [1]



A world-leading healthcare environment

As a market to develop new digital health solutions, or a launchpad into Southeast Asia, Australia is an ideal place to do business. There are more than 30 incubators and accelerators across the country, with ANDHealth providing a dedicated ecosystem for the development and commercialisation of evidence-based digital health products.

Supported by a highly skilled and technology-driven workforce and backed by leading research institutions, Australian expertise across medtech and health is world class.

Australia has been ranked first in the developed world for health care outcomes and administrative efficiency and second overall for our healthcare system by the Commonwealth Fund. Our healthcare system delivers long life expectancy at a low cost - just US$4,207 per capita, compared with US$9,364 for the US. [2]

Our leadership of the Global Digital Health Partnership, a collaboration of 23 countries and the World Health Organisation, reflects our commitment to and excellence in digital health.

Australia’s digital health market, valued at US$1.488 billion in 2017, is expected to grow to US$1.851 billion in 2020. [3]



Opportunities for collaboration

The Australian Digital Health Agency’s National Digital Health Strategy 2018–2022 proposes a number of pioneering initiatives co-produced between consumers, governments, researchers, providers and industry. [4]

Opportunities for international expertise include:

  • Investing in the integrated management of chronic illness
  • Developing new digital services to support the health of babies and young children
  • Improving digital services for advanced care planning
  • Improving information sharing in urgent and emergency care
  • Widening access to telehealth services, particularly in rural and regional Australia.


Global investment pathways

Australia provides a unique opportunity for investors to trial solutions here or grow existing businesses, then leverage international regulatory compatibility to enter global markets. In addition, Australia’s numerous Free Trade Agreements ensure enhanced access to key markets.

Examples of global digital health research collaboration in Australia include:

  • US conglomerate Johnson & Johnson has opened an Innovation Partnering Office at Monash University in Victoria. JJIPO@MONASH is the Victorian headquarters for Johnson & Johnson’s scientific, investment and commercialisation arms and identifies medtech projects for potential collaboration and commercialisation.
  • Fujifilm Medical Systems partnered with Alcidion to develop an intelligent cardiovascular information system that delivers advanced decision support to cardiovascular clinicians.
  • IP Group plc, a UK-based intellectual property (IP) commercialisation company, has committed to invest at least $200 million over a 10-year period to fund investments in spin-out companies based on the IP developed by academics at eight Australian universities, generated from research in areas such as digital medicine, new medical therapies and quantum computing. [5]


Tap into government funding and tax rebates

The Australian Government supports productive foreign investment partners through the Medical Research Future Fund  ($20 billion endowment by 2020) to collaborate with Australian organisations.

Foreign investment partners can also access the Biomedical Translation Fund ($500 million) to co-invest in emerging Australian biomedical companies with licensed Australian venture capital firms.

Research and development (R&D) tax rebates as well as Australians’ enviable lifestyle helps attract and retains world-class talent, which in turn can help your business achieve its goals in this region.

_________________________
[1] Australia Speaks 2018
[2] The Commonwealth Fund. Mirror, Mirror 2017: International Comparison Reflects Flaws and Opportunities for Better U.S. Health Care. July 14, 2017. Eric C. Schneider, M.D., Dana O. Sarnak, David Squires, Arnav Shah, and Michelle M. Doty
[3] Frost and Sullivan. Global Digital health Outlook 2018
[4] Australian Digital Health Agency, Australia’s National Digital Health Strategy: Safe, Seamless and Secure , July 2018, accessed 11 January 2019.
[5] IP Group plc - Commits A$200m in landmark deal with 9 leading universities in Australia and New Zealand